Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGN6C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,899
Award facts
- Contract value 100% obligated
- $10,898.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,898.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pens on February 4, 2026, with completion targeted for February 5, 2026. The contract was competitively awarded with no set-aside designation and specifies performance at the awardee's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026 and serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a subsidiary of parent company Cencora, Inc. The company maintains an extensive portfolio of federal medical procurement contracts covering a broad spectrum of pharmaceutical products and medical supplies, including diabetes medications, specialty treatments, and critical care materials. The Zepbound delivery order represents a discrete transaction under the firm fixed-price structure typical of DLA pharmaceutical procurement, supporting the agency's mission to provide medical commodities to military treatment facilities and veterans' healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FGN6C?
SPE2DR26FGN6C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FGN6C worth?
The government has obligated $10,899 on SPE2DR26FGN6C.
Is contract SPE2DR26FGN6C an order under another contract?
Yes. SPE2DR26FGN6C is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGN6C competed?
The extent of competition for SPE2DR26FGN6C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award